BIOREM Technologies Inc.
TSX VENTURE : BRM

BIOREM Technologies Inc.

September 07, 2005 12:11 ET

BIOREM And Ecovation Sign License Agreement

GUELPH, ONTARIO--(CCNMatthews - Sept. 7, 2005) - NOT FOR U.S. DISTRIBUTION

BIOREM Inc. (TSX VENTURE:BRM) announced today that it has entered into an exclusive license agreement with Ecovation, Inc., Victor, NY to use BIOREM's biofilter odour control technology in the food & beverage market in the United States and Mexico. Under the terms of the license agreement, BIOREM will receive royalties, which are payable over the five year term of the agreement, plus continuing revenues generated from the sale of BIOSORBENS™ filter media used in the licensed applications.

Ecovation manufactures the patented Mobilized Film Technology (MFT(SM)) anaerobic wastewater treatment system for industrial manufacturers and the BIOREM technology will complement the Ecovation technology. Ecovation will focus primarily on the food & beverage industry and has multiple facilities installed and operating for major Fortune 500 companies. Ecovation's unique business model assumes responsibility of installation and operation of on-site wastewater treatment for the client, providing reduced operating costs. The decrease in effluent loadings on municipal wastewater treatment plants permits increased plant production and provides improved compliance status.

"Ecovation's dedicated, specialized sales force provides us with distribution to the entire food & beverage industry that we would otherwise be unable to cover in a comprehensive manner," said Brian Herner, president and CEO of BIOREM. "Odour control will be used on both wastewater treatment emissions and on the treatment of air emissions from plant operations. There are millions of dollars of sales opportunities that are untapped in this industry and working with Ecovation will provide us both additional revenue streams that would otherwise be missed."

"Ecovation chose to license BIOREM's technology after careful evaluation of the alternatives available for odour control," said Ms. Diane C. Creel, chairman and CEO of Ecovation. "Their technology is one that fits in well with our business strategy and provides a product that will generate additional market opportunities. The license approach allows us to provide our customers with immediate access to BIOREM's established, leading biological odour control product."

About BIOREM

BIOREM® manufactures BIOSORBENS™ biofilter media and is a leading supplier of biofilters for air pollution control in municipal and industrial applications, including the recently acquired BIOCUBE® modular units. With over 400 installed systems and over a decade of experience, the company's biofilters are the technology of choice for odor control at Wastewater Treatment Plants across North America. www.biorem.biz

About Ecovation

Ecovation provides value-driven, sustainable solutions to meet the wastewater management needs of industrial clients. Ecovation's customized wastewater treatment solutions include the patented Mobilized Film Technology (MFT(SM)), which provides superior treatment of high-strength organic wastes, as well as the Krofta Technologies' line of dissolved air flotation (DAF) and filtration (DAFF) treatment systems for solids removal. Based in Victor, NY, Ecovation has multiple facilities installed and operating for major Fortune 500 clients. For more information, visit www.ecovation.com.

The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this release.

Forward-Looking Statements -

All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding the future plans and objectives of Biorem Inc. There can be no assurance that such statements will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

Contact Information

  • BIOREM Technologies Inc.
    Tim Gallagher
    Investor Relations
    (519) 767-9100
    or
    BIOREM Technologies Inc.
    Greg Flanagan
    CFO
    (519) 767-9100
    ir@biorem.biz
    or
    Ecovation inc
    Ken Garcia
    CFO
    Suite 200 Eastgate Square
    50 Square Drive
    Victor, NY 14564 USA